Evidence map›Paper›PMID 37760682›Full record

ArticleAntibiotics (Basel, Switzerland)2023

SK-03-92 Drug Kills Intracellular

William R Schwan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

William R SchwanDepartment of Microbiology, University of Wisconsin-La Crosse, 1725 State St., La Crosse, WI 54601, USA.ORCID 0000-0003-3076-1815
University of Wisconsin–La Crosse · US

Funding

Foundation for the National Institutes of Health HHSN272201100012I
6 · The paper itself

Abstract

backgroundTuberculosis affects millions of people worldwide. The emergence of drug-resistant

methodsFor this study, an MIC analysis and intracellular killing assay were performed to test SK-03-92 against

resultsThe MIC analysis showed that SK-03-92 had activity against

conclusionTogether, the data show the SK-03-92 lead compound can kill

Indexed as

macrophageMycobacterium tuberculosisSK-03-92stilbene

Identifiers

PMID37760682
PMCPMC10525840
OpenAlexW4386283035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.